[go: up one dir, main page]

BE906034A - Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques - Google Patents

Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques

Info

Publication number
BE906034A
BE906034A BE0/217600A BE217600A BE906034A BE 906034 A BE906034 A BE 906034A BE 0/217600 A BE0/217600 A BE 0/217600A BE 217600 A BE217600 A BE 217600A BE 906034 A BE906034 A BE 906034A
Authority
BE
Belgium
Prior art keywords
water
active ingredient
pharmaceutical compositions
compositions containing
therapeutic applications
Prior art date
Application number
BE0/217600A
Other languages
English (en)
Inventor
Pierre-Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of BE906034A publication Critical patent/BE906034A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Compositions pharmaceutiques aqueuses contenant de l'ubiquinone, un émulsifiant non ionique, un solvant hydroxylé, des agents anti-oxydants et éventuellement du diméthylacétamide. L'administration des compositions selon l'invention par les voies orales, parentérales et topiques sont hydrosolubles et stables, n'entrainant pas de phénomènes de précipitation du principe actif. Leur biodisponibilité améliorée (meilleure absorption du principe actif) entraine une efficacité thérapeutique accrue.
BE0/217600A 1985-12-24 1986-12-23 Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques BE906034A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5525/85A CH667387A5 (it) 1985-12-24 1985-12-24 Formulazioni farmaceutiche acquose di ubichinone.

Publications (1)

Publication Number Publication Date
BE906034A true BE906034A (fr) 1987-04-16

Family

ID=4295081

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217600A BE906034A (fr) 1985-12-24 1986-12-23 Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques

Country Status (7)

Country Link
JP (1) JPS62158209A (fr)
BE (1) BE906034A (fr)
CH (1) CH667387A5 (fr)
DE (1) DE3643330A1 (fr)
FR (1) FR2598320B1 (fr)
GB (1) GB2184355B (fr)
IT (1) IT1198247B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076433A1 (fr) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Preparation dentaire

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250672B (it) * 1991-07-11 1995-04-21 Idb Holding Spa Formulazioni orali di ubidecarenone in soluzione acquosa
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
GR1001364B (el) * 1992-10-16 1993-10-29 Inverni Della Beffa Farma Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων.
WO1998035658A2 (fr) * 1997-02-12 1998-08-20 Mse Pharmazeutika Gmbh Utilisation de 2,3-dimethoxy-5-methyle-6-decaprenyle-1,4-benzoquinone
EP1398026B1 (fr) * 1997-02-12 2006-06-21 MSE Pharmazeutika GmbH Utilisation de 2,3-dimethoxy-5-methyle-6-decaprenyle-1,4-benzoquinone dans le traitement de l'incontinence
US5925335A (en) * 1997-06-12 1999-07-20 C.S. Bioscience Inc. Dental formulation
EP0888774A3 (fr) * 1997-06-30 1999-11-10 Soft Gel Technologies, Inc. Formulation de gel contenant la coenzyme Q10
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
JPWO2005035477A1 (ja) * 2003-10-08 2007-11-22 株式会社カネカ キノン骨格を有する化合物の安定化方法及び安定化された組成物
CA2587677C (fr) 2004-11-16 2013-05-28 Bioavailability, Inc. Preparations autoemulsifiantes a concentration elevee a base de coenzyme q10 a usage nutritionnel
JP5722299B2 (ja) * 2012-12-07 2015-05-20 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
JP5999765B2 (ja) * 2012-12-07 2016-09-28 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (fr) * 1961-03-06 1963-08-16 Merck & Co Inc Solutions aqueuses stables à base de benzoquinone substituée
NL275602A (fr) * 1961-03-06
JPS498246B1 (fr) * 1965-07-15 1974-02-25
GB1225979A (fr) * 1967-03-23 1971-03-24
GB1317865A (en) * 1971-11-15 1973-05-23 Jujo Paper Co Ltd Biologically active composition
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076433A1 (fr) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Preparation dentaire

Also Published As

Publication number Publication date
GB2184355A (en) 1987-06-24
GB2184355B (en) 1990-03-28
GB8630158D0 (en) 1987-01-28
JPH0455404B2 (fr) 1992-09-03
IT8622844A0 (it) 1986-12-23
CH667387A5 (it) 1988-10-14
DE3643330A1 (de) 1987-06-25
IT8622844A1 (it) 1988-06-23
JPS62158209A (ja) 1987-07-14
FR2598320A1 (fr) 1987-11-13
FR2598320B1 (fr) 1990-11-02
IT1198247B (it) 1988-12-21

Similar Documents

Publication Publication Date Title
BE906034A (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
FR2430228A1 (fr) Medicament contre les maladies de la peau
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
ES2113127T3 (es) Derivado de androstenona.
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
MX9307779A (es) Compuestos benzoicos fundidos.
BR9810312A (pt) Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
BR9810729B1 (pt) composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
ATE87484T1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO870560L (no) Nytt farmasoeytisk preparat.
ATE173627T1 (de) Medizinische zusammensetzung
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
FR2356425A1 (fr) Application a titre de medicaments de derives organiques de la montmorillonite
FR2398067A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
ES457805A1 (es) Un procedimiento para la preparacion de derivados de tiou- rea.
BE901963A (fr) Forme dosee d'etoposide a usage oral.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SEUREF A.G.

Effective date: 19931231